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 Secretory immunoglobulin A (sIgA) is a crucial 
factor in protection of the gastrointestinal (GI) tract mucosa 
directly providing the first line of defense of the intestine 
from the impact of foreign antigens. sIgA is considered to 
be a key cleaner of the intestine because it is a basic 
effector molecule of the mucosal immunity system and it 
comprises most immunoglobulins of the intestinal 
discharge. Maintenance of the homeostatic equilibrium 
between the intestinal microbiota and the plethora of 
luminal macromolecules and the human intestinal 
epithelial cell barrier requires the secretion of copious 
amounts of mucosal IgA into the gut lumen. In humans, 
40–60 mg/kg/day of IgA are produced daily by plasma 
cells located in the lamina propria (LP) of intestinal villi, 
that is almost 1.5 times more than daily IgG production 
about (30 mg/kg/day). And production tends to peak in 
childhood and start to decline after about sixty years old. 
The IgA is transported across the epithelium and secreted 
into the gut lumen, where it is thought to provide protection 
against pathogens by multiple biological properties, which 
include blocking toxins and pathogens from adhering to the 
intestinal epithelium at the earliest steps of the infection 
process, and from directly recognizing receptor-binding 
domains to block bacterial attachment to intestinal 
epithelial cells [1, 2].  At the same time, sIgA is able to 
form immune complexes not only with infectious agents 
and their constituent elements, which are found in the 
mucous membrane, but also with those, which for some 
reasons overcome the epithelial barrier and directly 
penetrate lamina propria [3, 4]. Most B-cells secreting IgA 
are commonly known to be located in GI, 
bronchopulmonary, genitourinary tracts mucosa [5, 6]. The 
release of sIgA from plasma cells occurs influenced by IL-
4, IL-5, IL-6, IL-10 cytokines [7, 8].  
 According to researchers, sIgA decrease can be 
indicative of insufficient function of the local immunity 
and its increased level shows that there is immune system 
imbalance [9, 10].  Formation of long-term infectious 
processes as well as chronic pathology associated with 
increased local immunity, sIgA in particular, is considered 
in a range of studies [11, 12, 13]. sIgA deficiency in GI 
tract results in damage of intestinal “biofilm”, increased 
activity of aggressive compounds, impaired colonization 
resistance of the mucosa; it provides conditions for long-
term course of intestinal infection [14, 15, 16]. Not only 
clinical trial data, but also laboratory experiment findings 
prove a particular role of sIgA in protection against 
pathogenic enterobacteria including shigella as the most 
frequent causative agents of bacterial intestinal infections 
in children [17].  
 The local immunity factors are of great importance 
in combination with two or more pathogenic causative 
agents that can be present in the intestine for a long time. 
As it is commonly known, infection with Helicobacter 
pylori, observed at an early age, becomes more and more 
widespread over the last years [18, 19]. The global burden 
of Shigellosis is still quite significant. There are no good 
estimates of the country-specific geographic distribution of 
this disease. However, between 120 and 165 millions 
incident cases are believed to occur each year. 
Furthermore, approximately 1 millions deaths occur 
annually, with greater than 60% of these experienced by 
children under 5 years of age [20]. Taking into 
consideration that Shigellosis mortality rate among 
children is still high up to now, the issue focused on local 
immunity state in children with Shigellosis, infected with 
Helicobacter pylori is currently of concern. Unfortunately, 
we did not find data dealing with this issue in the 
information sources available.  
Purpose of the study is to define the status of local 
immunity in children with Shigellosis, infected with 
Helicobacter pylori, by identifying one of its main 
components – the level of sIgA in coprofiltrate.  
 
Materials and methods. The study involved 68 children 
aged from 1 to 3, who were hospitalized in Regional 
Children’s Infectious Diseases Hospital (Kharkiv) and 
diagnosed with Shigellosis due to Shigella Sonnei of 
moderate severity. The diagnosis was made based on 
clinical epidemiological data along with verification of an 
etiological causative agent via bacteriological and/or 
serologic methods. In addition to the commonly used 
research methods, children were tested for H. pylori 
presence by polymerase chain reaction (PCR) method and 
an immunochromatographic assay for detecting Hp 
antigens in fecal specimens CITO TEST H.PyloriAg 
(CerTest Biotec, S.L., Spain, «Pharmasco») and for the 
level of sIgA in coprofiltrate in the dynamics of the 
pathological process by immune-enzyme assay using the 
standard set applying "Immunoglobulin A secretory - IFA- 
BEST". The studies were conducted in acute period (1-2 
days of illness) and in the period of early reconvalescence 
(5-7 days of illness), if necessary – more often. The 
treatment of children was carried out in accordance with 
approved clinical protocols (Order N 354 of 09.07.2004 
"On the approval of protocols for the diagnosis and 
treatment of infectious diseases in children"). 
 The patients were divided into two group: Group 1 
(31 children) was made up by children with Shigellosis 
with confirmed H. pylori infection and Group 2 (37 
children) – children with Shigellosis without laboratory 
markers of Helicobacter infection. The study groups were 
compared based on age (26.35±4.74 and 24.49±6.27 
months, p>0.05), sex and comorbidity. The control group 
was represented by 20 apparently healthy children of the 
same age and sex who were not infected with H. Pylori and 
whose rates were taken as reference values. Statistical 
processing of the obtained data was carried out by means 
of Excel and Statistica 6.0 applications. The significance of 
difference between the groups was estimated via Student’s 
test (Student’s t-test), correlation between the parameters – 
via the Pearson correlation coefficient (r).   
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Results and discussion. In order to achieve the 
purpose, we compared basic clinical laboratory values of 
the study groups. It was revealed, that in the children with 
background infection with H. pylori, the fever was present 
longer (4.61±0.15 days vs 3.42±0.14, p<0.05) as well as 
regurgitation and/or (3.43±0.38 vs 2.09±0.15 days, 
p<0.05), loss of appetite (5.2±0.62 and 2.08±0.25 days, 
p<0.05), asthenoneurotic syndrome manifestations 
(4.78±0.28 and 3.06±0.17 days, p<0.05); the 
comprocytogram changes were also more long-term 
(6.68±0.33 and 3.85±0.16 days respectively, p<0.05), 
which were mainly characterized by longer preservation of 
vegetable and muscle fibers in patients of the first group. 
The findings detected are indicative of substantial 
differences in the course of Shigellosis depending on 
present background infection in a child.  The study 
outcomes concerned with sIgA in the patients of both 
groups in acute period and early convalescence of 
Shigellosis are presented in the Table below.    
 
Table. Secretory IgA content values in coprofiltrates of 
patients at different Shigellosis stages, mg/l, 
(M±m)  
Disease stage 
Group 1 
(n = 31) 
Group 2 
(n = 37) 
Control 
(n =20) 
Acute period 
1.06±0.031,
2 
1.18±0.04
1 
Convalescens
e  period 
0.86±0.031 0.98±0.02 
Note: feature significance 
1. р1<0.05concerned with healthy children  
2. р2<0.05 between values of children in the 
groups 
 
 
Significantly higher sIgA level, in comparison 
with the same values of the control group, (p˂0.05), was 
revealed in coprofiltrates of all children in acute period. At 
the same time, in children of Group 2 sIgA content was 
significantly higher than the values of patients0 with 
background infection, (p˂0.05).   
The quantitative sIgA content restored and 
significantly did not differ from the values of the control 
group (р˃0.05) in early convalescence period of 
Shigellosis in children without background infection. 
However, significant difference was observed with the 
acute period value (р<0.05). sIgA concentration in children 
infected with H. pylori in the period of clinical recovery 
was significantly decreased in comparison with acute 
period values (p<0.05). It was significantly different from 
the data of healthy children and the children of Group 2, 
(p<0.05). The findings obtained are indicative of 
imbalance of local immunity competence of the intestine 
in Shigellosis in children infected with H. pylori, especially 
impaired sIgA production. Insufficient sIgA secretion in 
coprofiltrates of patients with Shigellosis, that has been 
revealed, is not contrary to the hypothesis of some 
scientists concerning the capacity of pathogenic H. pylori 
strains to carry out their cytotoxic effect associated with 
decrease of local protective mechanisms of the GI tract 
mucosa as well as system immunity, the ability to spin out 
of control of specific immunity mechanisms up to 
development of immune-dependent inflammation forms 
[18, 19].  
Taking the revealed differences of sIgA content in 
coprofiltrates in Shigellosis in patients with and without 
background infection with H. pylori into consideration, we 
have carried out the study of correlational connection 
concerned with assessment of Pearson coefficient of this 
value with basic clinical laboratory values in the acute 
period of Shigellosis in patients infected with H. pylori. 
The study of interrelation of the laboratory values of 
patients is crucial not only considering scientifically, but 
also in terms of applied medicine. The outcomes obtained 
show weak negative correlation between sIgA content and 
defecation intensity (frequency) (r=-0.18); negative 
direction correlation in relation to the duration of diarrheal 
syndrome (r=-0.18); medium intensity correlation in 
relation to duration and alterations degree in 
coprocytogram (r=-0.33). Present correlational interactions 
between sIgA values in coprofiltrates of children suffering 
from Shigellosis, infected with H. pylori, and frequency of 
development of specific symptoms along with their 
duration, are indicative of sIgA role in formation of 
pathogenic mechanisms of the disease course.  
Therefore, Shigellosis in children infected with H. 
pylori is accompanied by substantial impairment of local 
immunity competence that influences the frequency of 
manifestations of some clinical symptoms and pathologic 
changes of laboratory values, their duration.  The data 
obtained can become the theoretical basis for the 
improvement of treatment of children with Shigellosis, 
infected with H. pylori, with due regard to detected 
disturbance of local immunity competence.  
 
Conclusions 
1. Infection of children with H. pylori affects local 
immunity of the intestine, especially intestinal sIgA 
secretion  
2. Shigellosis in children infected with H. pylori proceeds 
in the form of hyporeactive reaction with substantially 
lower sIgA concentration in coprofiltates in acute period in 
comparison with the values in the patients who are not 
infected.  
3. Within the period of early convalescence in children 
suffering from Shigellosis, infected with H. pylori, 
significantly decreased sIgA content in coprofiltrates is 
observed. 
4. The revealed violations of sIgA in coprofiltrates in 
children with Shigellosis and infected with H. pylori may 
be a promising direction in the study of pathogenetic 
mechanisms for the formation of the pathological process..   
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Kurlan N.Yu. 
Introduction. Secretory immunoglobulin A (sIgA) is a 
crucial factor in protection of the gastrointestinal (GI) 
tract mucosa directly providing the first line of defense of 
the intestine from the impact of foreign antigens. At the 
same time, sIgA is able to form immune complexes not 
only with infectious agents and their constituent elements, 
which are found in the mucous membrane, but also with 
those, which for some reasons overcome the epithelial 
barrier and directly penetrate lamina propria. The release 
of sIgA from plasma cells occurs influenced by IL-4, IL-
5, IL-6, IL-10 cytokines. Formation of long-term 
infectious processes as well as chronic pathology 
associated with increased local immunity, sIgA in 
particular, is considered in a range of studies. The local 
immunity factors are of great importance in combination 
with two or more pathogenic causative agents that can be 
present in the intestine for a long time. Taking into 
consideration that Shigellosis mortality rate among 
children is still high up to now, the issue focused on local 
immunity state in children with Shigellosis, infected with 
Helicobacter pylori is currently of concern. Purpose of 
the study is to explore local immunity competence in 
children with Shigellosis, infected with Helicobacter 
pylori by means of sIgA level assessment. Materials and 
methods.  The study involved 68 children aged from 1 to 
3, who were diagnosed with Shigellosis Sonnei of 
medium severity. Additionally, the determination of H. 
pylori in feces and the level of sIgA in coprofiltrate were 
provided. Results and discussion.  Significantly higher 
sIgA level, in comparison with the same values of the 
control group, was revealed in coprofiltrates of all 
children in acute period. At the same time, in children of 
Group 2 sIgA content was significantly higher than the 
values of patients with background infection. The 
qualitative sIgA content restored and significantly did not 
differ from the values of the control group in early 
convalescence period of Shigellosis in children without 
background infection. However, significant difference 
was observed with acute period value. sIgA concentration 
in children infected with H. pylori in the period of clinical 
recovery was significantly decreased in comparison with 
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acute period values. It was significantly different from the 
data of healthy children and the children of Group 2. The 
findings obtained are indicative of imbalance of local 
immunity competence of the intestine in Shigellosis in 
children infected with H. pylori, especially impaired sIgA 
production. Insufficient sIgA secretion in coprofiltrates of 
patients with Shigellosis, that has been revealed, is not 
contrary to the hypothesis of some scientists concerning 
the capacity of pathogenic H. pylori strains to carry out 
their cytotoxic effect associated with decrease of local 
protective mechanisms of the GI tract mucosa as well as 
system immunity, the ability to spin out of control of 
specific immunity mechanisms up to development of 
immune-dependent inflammation forms. Taking the 
revealed differences of sIgA content in coprofiltrates in 
Shigellosis in patients with and without background 
infection with H. pylori into consideration, we have 
carried out the study of correlational connection 
concerned with assessment of Pearson coefficient of this 
value with basic clinical laboratory values. Present 
correlational interactions between sIgA values in 
coprofiltrates of children suffering from Shigellosis, 
infected with H. pylori, and frequency of development of 
specific symptoms along with their duration, are 
indicative of sIgA role in formation of pathogenic 
mechanisms of the disease course. Conclusion.  
Therefore, Shigellosis in children infected with H. pylori 
is accompanied by substantial impairment of local 
immunity competence that influences the frequency of 
manifestations of some clinical symptoms and pathologic 
changes of laboratory values, their duration.  The data 
obtained allow to assume as the perspective direction in 
perfection of therapy of such patients use of complex 
immunoglobulin medications should be aimed primarily 
at inflammatory processes stopping. Keywords. 
Shigellosis, immunoglobulins, children, Helicobacter 
pillory  
 
